ES2050651T3 - Medicamento transdermal. - Google Patents
Medicamento transdermal.Info
- Publication number
- ES2050651T3 ES2050651T3 ES87106884T ES87106884T ES2050651T3 ES 2050651 T3 ES2050651 T3 ES 2050651T3 ES 87106884 T ES87106884 T ES 87106884T ES 87106884 T ES87106884 T ES 87106884T ES 2050651 T3 ES2050651 T3 ES 2050651T3
- Authority
- ES
- Spain
- Prior art keywords
- active compound
- auxiliary
- matrix
- solid
- transdermal medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
MEDICAMENTOS TRANSDERMALES, CONTIENEN EN UNA MATRIZ VISCOSA COMO SUSPENSION SUSTANCIAS ACTIVAS O AUXILIARES O UNA SUSTANCIA ACTIVA ADSORBIDA EN UNA SUSTANCIA AUXILIAR SOLIDA, ESTA CARACTERIZADO YA QUE LA PREPARACION DE LA SUSPENSION SE EFECTUA A TRAVES DE UNA MOLIENDA HUMEDA EN PRESENCIA DE UNA SOLUCION VISCOSA DE LA MATRIZ O DE LA PARTE INTEGRANTE DETERMINADA EN CONDICIONES DE PEQUEÑA TEMPERATURA Y CIZALLAJE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3617158A DE3617158C2 (de) | 1986-05-22 | 1986-05-22 | Transdermales Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2050651T3 true ES2050651T3 (es) | 1994-06-01 |
Family
ID=6301334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87106884T Expired - Lifetime ES2050651T3 (es) | 1986-05-22 | 1987-05-12 | Medicamento transdermal. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4778678A (es) |
EP (1) | EP0246549B1 (es) |
JP (1) | JP2636849B2 (es) |
AT (1) | ATE101049T1 (es) |
CA (1) | CA1295942C (es) |
DE (2) | DE3617158C2 (es) |
ES (1) | ES2050651T3 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2612785A1 (fr) * | 1987-03-25 | 1988-09-30 | Lhd Lab Hygiene Dietetique | Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee |
DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
US4906475A (en) | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
US5273755A (en) * | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset |
US5234690A (en) * | 1991-08-23 | 1993-08-10 | Cygnus Therapeutic Systems | Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset |
US5273756A (en) * | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
US5629019A (en) * | 1992-02-27 | 1997-05-13 | Alza Corporation | Formulations with hydrophobic permeation enhancers |
EP0812197A2 (en) * | 1995-02-28 | 1997-12-17 | Beiersdorf-Lilly GmbH | Use of moxonidine for the treatment of atherosclerosis |
WO1997046241A1 (en) * | 1996-06-06 | 1997-12-11 | Eli Lilly And Company | Formulation and method for treating congestive heart failure |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2059276B (en) * | 1979-09-21 | 1983-05-11 | Coal Industry Patents Ltd | Controlling the filtration of solid and liquid mixtures |
JPS5714522A (en) * | 1980-06-09 | 1982-01-25 | Key Pharma | Polymer diffused matrix |
BE889926A (fr) * | 1980-08-11 | 1982-02-11 | Searle & Co | Tampon de nitroglycerine transdermique |
US4725272A (en) * | 1981-06-29 | 1988-02-16 | Alza Corporation | Novel bandage for administering beneficial drug |
US4661105A (en) * | 1981-06-29 | 1987-04-28 | Alza Corporation | Medical bandage for administering vasodilator drug |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
DE3315245A1 (de) * | 1983-04-27 | 1984-10-31 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches produkt |
DE3319469A1 (de) * | 1983-05-28 | 1984-11-29 | Akzo Gmbh, 5600 Wuppertal | System zur transdermalen applikation von pharmakotherapeutisch wirksamen substanzen |
US4590190A (en) * | 1983-07-01 | 1986-05-20 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
US4693887A (en) * | 1983-09-15 | 1987-09-15 | The Kendall Company | Microphase separated hydrogels for controlled release of bioactive materials |
DE3333444A1 (de) * | 1983-09-16 | 1985-04-11 | G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt | Transdermales therapeutisches system fuer arzneimittelwirkstoffe |
EP0156080B2 (en) * | 1984-03-05 | 1993-10-20 | Nitto Denko Corporation | Percutaneous absorption type adhesive pharmaceutical preparation |
DE3423293C2 (de) * | 1984-06-23 | 1995-08-24 | Lohmann Therapie Syst Lts | Selbstklebendes Pflaster |
US4687481A (en) * | 1984-10-01 | 1987-08-18 | Biotek, Inc. | Transdermal drug delivery system |
EP0177329B1 (en) * | 1984-10-05 | 1992-09-30 | Hercon Laboratories Corporation | Device for transdermal drug administration |
AU563054B2 (en) * | 1984-10-24 | 1987-06-25 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Percutaneous tape of isdn |
EP0204968B1 (de) * | 1985-05-24 | 1989-09-27 | Beiersdorf Aktiengesellschaft | Nitro-Pflaster |
-
1986
- 1986-05-22 DE DE3617158A patent/DE3617158C2/de not_active Expired - Fee Related
-
1987
- 1987-04-30 CA CA000536080A patent/CA1295942C/en not_active Expired - Lifetime
- 1987-05-04 US US07/046,377 patent/US4778678A/en not_active Expired - Lifetime
- 1987-05-12 DE DE87106884T patent/DE3788975D1/de not_active Expired - Fee Related
- 1987-05-12 ES ES87106884T patent/ES2050651T3/es not_active Expired - Lifetime
- 1987-05-12 AT AT87106884T patent/ATE101049T1/de not_active IP Right Cessation
- 1987-05-12 EP EP87106884A patent/EP0246549B1/de not_active Expired - Lifetime
- 1987-05-22 JP JP62124136A patent/JP2636849B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3788975D1 (de) | 1994-03-17 |
ATE101049T1 (de) | 1994-02-15 |
EP0246549A3 (en) | 1990-02-07 |
JPS62294611A (ja) | 1987-12-22 |
EP0246549A2 (de) | 1987-11-25 |
JP2636849B2 (ja) | 1997-07-30 |
DE3617158C2 (de) | 1994-10-06 |
EP0246549B1 (de) | 1994-02-02 |
US4778678A (en) | 1988-10-18 |
DE3617158A1 (de) | 1987-11-26 |
CA1295942C (en) | 1992-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
DK433584D0 (da) | Middel til transdermal applikation af stoffer, der er virksomme som laegemidler | |
DE69008423D1 (de) | Dynamische Fixierung von Schweinsaortaklappen. | |
PT77898B (en) | Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation | |
ES2050651T3 (es) | Medicamento transdermal. | |
FI891283A0 (fi) | Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning. | |
ATE109001T1 (de) | Mittel zur stimulierung der tränensekretion. | |
NO870397L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser. | |
NO864514D0 (no) | Fremgangsmaate for fremstilling av thiazoloner. | |
IL72188A0 (en) | Imidazoquinazoline derivative and salts thereof,their preparation and pharmaceutical compositions containing them | |
FI844645A0 (fi) | 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar. | |
NO881768L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
KR960006920A (ko) | 혈액 항응고제에 대한 해독제로서 사용하기에 적합한 약제 및 이의 용도 | |
DK131586A (da) | Transdermalt, antiallergisk, farmaceutisk praeparat | |
NO890681D0 (no) | Fremgangsmaate for fremstilling av alkanoyl- og aroyloxazoloner. | |
IT8620561A0 (it) | Procedimento e dispositivo per il trattamento di prodotti di uovo, o relativi composti, per prolungare la durata dei prodotti medesimi. | |
DE3378979D1 (en) | 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents | |
BR8901200A (pt) | Composicao anti-espuma solida,composicao agroquimica e processo para preparacao das mesmas | |
NZ230899A (en) | A combination preparation as an antidote for blood anticoagulants | |
NO165917C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn. | |
ES2061775T3 (es) | Derivados de estrobirulina, su obtencion y empleo. | |
NO822801L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner | |
IT8322401A0 (it) | Procedimento per la preparazione della 5-(e)-(2-bromovinil)-2'--desossiuri dina e dei suoi derivati, ederivati della 5-(e)-(2--bromovinil)-2'-desossiuri dina. | |
DE3878000D1 (de) | Verschmolzenes biologisches bekaempfungsmittel. | |
AR240063A1 (es) | Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 246549 Country of ref document: ES |